Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Brommer, Ida
DOB:	22-APR-1944 (Age: 81)
Gender:	female
Address:	Jacob van Ruysdaelstraat 100 5143 GM Waalwijk (Netherlands)
ID:	8212-076428-5

Report
Date:	05-APR-2025

Laboratory
dr Ample, Ex Boulevard du Jardin Botanique 32 1000 Brussels

Requested by
EHBO Europalaan 1 5171 Kaatsheuvel (Netherlands)

Specimen
Collected:	04-APR-2025

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	04 Apr 2025	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.9 H	4 - 6	%
Glucose [Mass/volume] in Blood	111.4 H	70 - 99	mg/dL
Urea nitrogen [Mass/volume] in Blood	8.8	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.5 L	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	8.7	8.6 - 10.2	mg/dL
Sodium [Moles/volume] in Blood	141.6	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.3	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	102.0	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	28.4	22 - 32	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	224.1 H	130 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	195.6 H	50 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	131.6 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	53.4	50 - 100	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	10.7	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated HbA1c and fasting glucose, indicating suboptimal glycemic control. Lipid profile reveals consistently high total cholesterol, LDL, and triglycerides, increasing cardiovascular risk. Renal function is stable with low-normal creatinine and normal microalbumin/creatinine ratio. Electrolytes and blood counts are within normal limits. Recommend optimization of diabetes and lipid management, and continued monitoring of renal and cardiovascular status.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistently elevated HbA1c and fasting glucose, indicating suboptimal glycemic control. Lipid profile reveals consistently high total cholesterol, LDL, and triglycerides, increasing cardiovascular risk. Renal function is stable with low-normal creatinine and normal microalbumin/creatinine ratio. Electrolytes and blood counts are within normal limits. Recommend optimization of diabetes and lipid management, and continued monitoring of renal and cardiovascular status.